Nuvation Bio Inc. (NUVB-WT) Comparison with companies in other sectors?

Nuvation Bio Inc. has a share price of 2.77B. You can analyze Nuvation Bio Inc. (NUVB-WT) competitors across different market sectors through stock heatmaps.

What are NUVB-WT's NET and operating margins?

Nuvation Bio Inc. (NUVB-WT) operating margin is around -57.63, and net profit margin is approximately -55.34 as of the latest reports.

In what way does NUVB-WT's earnings per share (EPS) trend reflect its financial momentum?

Nuvation Bio Inc. (NUVB-WT) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Nuvation Bio Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Nuvation Bio Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Nuvation Bio Inc. like P/E which is -1.29, P/B which is 1.86, and PEG which is 0.32. Compare them with sector averages to evaluate if the stock is priced fairly.

Nuvation Bio Inc.

NUVB-WT•NYSE

Healthcare

Biotechnology

$0.26

$0.01(4.000%)

Fundamental Analysis of Nuvation Bio Inc. (NUVB-WT)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

P/E Ratio

ROE

-1.48%

Net Margin

-55.34%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$773.06M

Shares OutstandingTotal number of shares issued

$2.77B

Book Value/ShareNet worth per share

$1.24

Revenue/ShareAnnual revenue per share

$0.03

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

-5534.21%

Operating MarginOperating income as percentage of revenue

-5762.82%

ROEReturn on shareholders' equity

-147.61%

ROAReturn on total assets

-123.13%

ROCEReturn on capital employed

-143.60%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.47

Cash/ShareCash and equivalents per share

$1.36

FCF YieldFree cash flow as percentage of market cap

-20.19%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NUVB-WTFinancial Ratios Analysis details for NUVB-WT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NUVB-WTSector Benchmarking details for NUVB-WT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Nuvation Bio Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Nuvation Bio Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Nuvation Bio Inc.'s unique business strengths and challenges.

Key Financial Metrics for Nuvation Bio Inc.

For Nuvation Bio Inc., essential financial indicators include EPS -, PE -, and ROE -1.48. These key ratios reveal insights into Nuvation Bio Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Nuvation Bio Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Nuvation Bio Inc.

Metrics like Net Margin -5534.21% and ROA -123.13% shed light on how well Nuvation Bio Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Nuvation Bio Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Nuvation Bio Inc.

Using ratios such as P/B Ratio 1.86 and PEG Ratio 0.32, investors can assess whether Nuvation Bio Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Nuvation Bio Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Nuvation Bio Inc.

Financial health indicators, such as Debt/Equity Ratio 0.03 and Cash Flow $-0.47, provide a snapshot of Nuvation Bio Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Nuvation Bio Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Nuvation Bio Inc.

Investing in Nuvation Bio Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Nuvation Bio Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;